OBJECTIVES The aims of this study were to: 1) use a novel method of late gadolinium enhancement (LGE) quantification that uses normalized intensity measures to confirm the association between LGE extent and atrial fibrillation (AF) recurrence following ablation; and 2) examine the presence of interaction and effect modification between LGE and AF persistence.
A trial fibrillation (AF) is associated with increased risk for mortality, heart failure, and thromboembolic events and has a worldwide prevalence of >33.5 million (1-3). Catheter ablation of AF is evolving as an effective therapy for symptomatic AF (4) . Recurrent AF after ablation, however, remains a problem and has been reported to associate with the baseline extent of left atrial (LA) late gadolinium enhancement (LGE) on cardiac magnetic resonance (CMR) (5) . Mechanistically, persistent AF appears to be more reliant on fibroblast proliferation and myocyte-fibroblast coupling than paroxysmal AF, which is dependent primarily on pulmonary vein triggers (6) (7) (8) . Therefore, we sought to:
1) confirm the association of LA LGE with recurrent AF following ablation; and 2) examine the presence of interaction and/or effect modification between
LGE and AF persistence prior to ablation.
METHODS PATIENT CHARACTERISTICS. The Johns Hopkins
Institutional Review Board approved the study, and all patients provided written informed consent.
Between November 2011 and December 2013, 171
consecutive patients with drug-refractory AF who were referred for initial catheter ablation procedures, were scheduled for a pre-procedural CMR, and consented to participate were prospectively enrolled.
CMR. All subjects underwent pre-procedural CMR as previously described (9) (10) (11) . Images were acquired using a 1.5-T CMR scanner (Avanto, Siemens, Erlangen, Germany) with a phased-array cardiac coil. Pulse oximetry, blood pressure, and electrocardiographic monitoring were maintained during the CMR examination. Contrast-enhanced 3-dimensional fast lowangle shot magnetic resonance angiographic images were used to define LA and pulmonary vein anatomy.
LGE LGE = late gadolinium enhancement PVI = pulmonary vein isolation
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LGE, AF Type, and Recurrence Post-Ablation knots at the 5th, 50th, and 95th percentiles (13) . Results were also visualized using Kaplan-Meier survival curves and log-rank tests. The possibility of multiplicative and additive interaction between our main effect variable (LA LGE extent) and AF type, as well as effect modification by AF type, was explored (14) .
Additive interaction was explored using the relative excess risk due to interaction, the attributable proportion due to interaction, and the synergy index (15, 16 LGE were associated with AF recurrence ( Table 2) .
In unadjusted analysis, each 10% increase in the extent of baseline LA LGE was associated with 1.5-fold increased hazard of AF recurrence (hazard ratio LGE extent. Khurram et al.
LGE, AF Type, and Recurrence Post-Ablation However, as demonstrated in Figure 3 , the magnitude of association between baseline LGE extent >35% and AF recurrence was attenuated when the cohort was stratified on the basis of AF type. In patients with paroxysmal AF, the HR for AF recurrence with baseline LGE extent >35% was 3.6 (95% CI: 1.7 to 7.7; p ¼ 0.001) after adjusting for age, LA volume, and history of congestive heart failure or coronary or peripheral vascular disease. In contrast, in patients with persistent AF, the HR for AF recurrence with LGE extent >35% was 6.5 (95% CI: 2.1 to 19.6; p ¼ 0.001) after adjusting for the same covariates. 
DISCUSSION
The main finding of the present study is that regardless of AF persistence at baseline, LGE #35% of LA myocardium, measured using the IIR, is associated with a favorable outcome, whereas LGE >35% is associated with early AF recurrence post-ablation.
PRIOR STUDIES OF THE ASSOCIATION OF LA LGE
WITH AF RECURRENCE POST-PVI. Our study is in agreement with prior reports of an association between AF recurrence and LA LGE extent. Peters et al. (18) were the first to use LGE magnetic resonance imaging for the detection of post-ablation PVI lesions within LA myocardium. Several follow-on studies reported that AF recurrence was negatively Values are n (%) or mean AE SD.
Abbreviations as in Table 1 . The model was adjusted for age, LA volume, AF type, and history of congestive heart failure or coronary or peripheral vascular disease.
LGE, AF Type, and Recurrence Post-Ablation Although LA wall image intensity on LGE CMR varies primarily as a function of gadolinium retention in fibrotic regions, it is also affected by parameters such as surface coil proximity, contrast dose, delay time of image acquisition after contrast injection, patient hematocrit, glomerular filtration rate, and body mass index. To overcome the limitations of the "arbitrary unit scale" as well as improve objectivity and generalizability, we used the IIR for quantification of LGE.
In a prior study, we showed that the IIR is closely associated with local intracardiac bipolar LA voltage measures and exhibits favorable intraclass correlations (>0.9) for interobserver and intraobserver variability and reliability of measurement (11) . It should be noted, however, that given the variable methodologies for acquisition and analysis of LGE images,
LGE prevalence and extent should not be compared among the different studies. It is our hope that the use of a standardized technique, as described here, will improve the future ability to compare results across cohorts. Nevertheless, the overall results are consistent, and increasing LGE appears to be associated with AF recurrence in all studies to date.
INTERACTION AND EFFECT MODIFICATION WITH AF
TYPE. To our knowledge, this is the first study to examine the presence of interaction or effect modification between LGE and AF type. Paroxysmal AF appears to be related to triggered activity primarily from pulmonary vein foci (6) . Therefore, it was expected that AF ablation with PVI would be more efficacious in the subgroup of patients with paroxysmal AF (21) . In contrast, persistent AF appears to be more reliant on myocyte-fibroblast coupling, resulting in non-pulmonary vein triggered activity, as well as enhanced AF perpetuation due to fibroblast proliferation (7, 8) . We hypothesized that the association of AF recurrence with baseline LGE extent would be dependent on AF type prior to ablation. In this study, Time to first atrial fibrillation (AF) recurrence in 86 participants (52%) with late gadolinium enhancement (LGE) extent #35% (solid line) and 79 participants (48%) with LGE extent >35% of left atrial myocardium (dashed line) (p < 0.001). 
Subgroup
The forest plot summarizes multivariable adjusted hazard ratios (HRs) for atrial fibrillation (AF) recurrence. Models were adjusted for age, left atrial (LA) volume, AF type, and history of congestive heart failure or coronary or peripheral vascular disease. The magnitude of association between AF recurrence and late gadolinium enhancement (LGE) extent was higher among patients with persistent AF; however, there was no evidence for statistical interaction.
LGE, AF Type, and Recurrence Post-Ablation Recent results suggest that additional ablation does not necessarily reduce AF recurrence (22, 23) . Our results suggest that patients with persistent AF and
LGE #35% are likely to benefit from PVI without additional extensive ablations. 
CONCLUSIONS
Regardless of AF persistence at baseline, and after adjusting for potential confounders, participants with
LGE #35% had favorable outcomes, whereas those with LGE >35% had early AF recurrence after ablation.
These findings suggest that patients with LGE #35% of LA myocardium should be considered candidates for simple PVI regardless of AF persistence. Additionally, our results suggest that substrate modification ablation strategies in addition to PVI may have a role when
LGE extent exceeds 35% of LA myocardium.
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